Abstract: Through a first processing thread, a first database is accessed via a first API to retrieve a list of event objects of the first database. Through a second processing thread, for each of the event objects, participant identifiers (IDs) are determined from the event object. For each of the participant IDs, a domain ID is extracted from the participant ID. A list of one or more entity objects are identified based on the domain ID, where the entity objects are stored in a second database such as a task database storing and managing many tasks. At least one attribute of at least one of the entity objects is modified based of the participant ID and the domain ID, which generates a modified entity object. Through a third processing thread, any event objects that have been modified are transmitted to the second database via a second API over the network.

Abstract: A mosquito surveillance device includes one or more mosquito traps having a camera capable of taking images of mosquitos and transmitting the images electronically to a receiver. Suitable traps include an ovitrap, for example. Images may be transmitted from inside or outside the trap to a receiver using low bandwidth cellular phone networks. The images are processed and displayed using software forming mosquito data. The images may be analyzed and the number of live mosquitos identified, the number of dead mosquitos identified, the species of mosquitos identified, or mapped vector densities in real time identified preferably at high resolution.

Abstract: A mosquito surveillance device includes one or more mosquito traps having a camera capable of taking images of mosquitos and transmitting the images electronically to a receiver. Suitable traps include an ovitrap, for example. Images may be transmitted from inside or outside the trap to a receiver using low bandwidth cellular phone networks. The images are processed and displayed using software forming mosquito data. The images may be analyzed and the number of live mosquitos identified, the number of dead mosquitos identified, the species of mosquitos identified, or mapped vector densities in real time identified preferably at high resolution.

Abstract: Through a first processing thread, a first database is accessed via a first API to retrieve a list of event objects of the first database. Through a second processing thread, for each of the event objects, participant identifiers (IDs) are determined from the event object. For each of the participant IDs, a domain ID is extracted from the participant ID. A list of one or more entity objects are identified based on the domain ID, where the entity objects are stored in a second database such as a task database storing and managing many tasks. At least one attribute of at least one of the entity objects is modified based of the participant ID and the domain ID, which generates a modified entity object. Through a third processing thread, any event objects that have been modified are transmitted to the second database via a second API over the network.

Abstract: Through a first processing thread, a first database is accessed via a first API to retrieve a list of event objects of the first database. Through a second processing thread, for each of the event objects, participant identifiers (IDs) are determined from the event object. For each of the participant IDs, a domain ID is extracted from the participant ID. A list of one or more entity objects are identified based on the domain ID, where the entity objects are stored in a second database such as a task database storing and managing many tasks. At least one attribute of at least one of the entity objects is modified based of the participant ID and the domain ID, which generates a modified entity object. Through a third processing thread, any event objects that have been modified are transmitted to the second database via a second API over the network.

Abstract: Through a first processing thread, a first database is accessed via a first API to retrieve a list of event objects of the first database. Through a second processing thread, for each of the event objects, participant identifiers (IDs) are determined from the event object. For each of the participant IDs, a domain ID is extracted from the participant ID. A list of one or more entity objects are identified based on the domain ID, where the entity objects are stored in a second database such as a task database storing and managing many tasks. At least one attribute of at least one of the entity objects is modified based of the participant ID and the domain ID, which generates a modified entity object. Through a third processing thread, any event objects that have been modified are transmitted to the second database via a second API over the network.

Abstract: A device for assembling aggregations of adherent cells includes a gripper moveable within an assembly vessel that fixes aggregations of adherent cells at a membrane of the gripper and, by movement of the gripper, assembles aggregations of cells on a separate membrane within the vessel, thereby creating a three-dimensional assembly of aggregations of cells that fuse and can be employed in surgical procedures as a unitary tissue of adherent cells. The aggregations of cells, as assembled, can assume three-dimensional configurations distinct from any one of the component aggregations of cells assembled.

Abstract: The invention generally relates to the field of immunochemistry including antibody therapy, diagnostics, and basic research and specifically relates to the area of selecting affinity molecules such as natural antibodies, including artificial antibodies, antibody mimics, and aptamers. The invention relates particularly to a method of selecting affinity molecules using a homogeneous noncompetitive assay in a high throughput process.

Abstract: The invention generally relates to the field of immunochemistry including antibody therapy, diagnostics, and basic research and specifically relates to the area of selecting affinity molecules such as natural antibodies, including artificial antibodies, antibody mimics, and aptamers. The invention relates particularly to a method of selecting affinity molecules using a homogeneous noncompetitive assay in a high throughput process.

Abstract: Orthopedic fracture repair implants, systems and methods are disclosed. Implants include one or more biocompatible sleeves and struts. The implants, systems and methods are applied to bone fractures, such as segmentation fractures.

Abstract: The invention generally relates to the field of immunochemistry including antibody therapy, diagnostics, and basic research and specifically relates to the area of selecting affinity molecules such as natural antibodies, including artificial antibodies, antibody mimics, and aptamers. The invention relates particularly to a method of selecting affinity molecules using a homogeneous noncompetitive assay in a high throughput process.

Abstract: A device for assembling aggregations of adherent cells includes a gripper moveable within an assembly vessel that fixes aggregations of adherent cells at a membrane of the gripper and, by movement of the gripper, assembles aggregations of cells on a separate membrane within the vessel, thereby creating a three-dimensional assembly of aggregations of cells that fuse and can be employed in surgical procedures as a unitary tissue of adherent cells. The aggregations of cells, as assembled, can assume three-dimensional configurations distinct from any one of the component aggregations of cells assembled.

Abstract: Orthopedic fracture repair implants, systems and methods are disclosed. Implants include one or more biocompatible sleeves and struts. The implants, systems and methods are applied to bone fractures, such as segmentation fractures.

Abstract: The invention generally relates to the field of immunochemistry including antibody therapy, diagnostics, and basic research and specifically relates to the area of selecting affinity molecules such as natural antibodies, including artificial antibodies, antibody mimics, and aptamers. The invention relates particularly to a method of selecting affinity molecules using a homogeneous noncompetitive assay in a high throughput process.

Abstract: The invention generally relates to the field of immunochemistry including antibody therapy, diagnostics, and basic research and specifically relates to the area of selecting affinity molecules such as natural antibodies, including artificial antibodies, antibody mimics, and aptamers. The invention relates particularly to a method of selecting affinity molecules using a homogeneous noncompetitive assay in a high throughput process.

Abstract: The invention generally relates to the field of immunochemistry including antibody therapy, diagnostics, and basic research and specifically relates to the area of alternatives to natural antibodies including artificial antibodies or antibody mimics. The invention relates particularly to the cooperative assembly of stable affinity complexes.

Abstract: A document imaging system is configured to allow scanning and transmission of document images. A scanner system images a document and wirelessly transmits the image to a personal digital assistant (PDA). The PDA transmits the image to a document server located on a network. An authenticated user may then retrieve a scanned document image from the document server via the network. Because the scanner system and/or PDA may be located in a remote location, remote documents may be quickly presented for viewing by a user.

Abstract: Devices and methods for treatment of a patient's vasculature with some embodiments configured for delivery with a microcatheter for treatment of the cerebral vasculature of a patient. Some embodiments may include the deployment of multiple permeable shell devices within a single vascular defect.

Abstract: The invention generally relates to the field of immunochemistry including antibody therapy, diagnostics, and basic research and specifically relates to the area of selecting affinity molecules such as natural antibodies, including artificial antibodies, antibody mimics, and aptamers. The invention relates particularly to a method of selecting affinity molecules using a homogeneous noncompetitive assay in a high throughput process.

Abstract: The invention generally relates to the field of immunochemistry including antibody therapy, diagnostics, and basic research and specifically relates to the area of alternatives to natural antibodies including artificial antibodies or antibody mimics. The invention relates particularly to the cooperative assembly of stable affinity complexes.